---
title: "28 companies disclosed their repurchase progress, with FOSUN PHARMA, Allmed, and NHD having the highest repurchase plan amounts"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/225904021.md"
description: "On January 23, 28 companies announced stock repurchase plans, among which 4 companies disclosed their repurchase plans for the first time, 1 company's plan was approved by the shareholders' meeting, 13 companies disclosed implementation progress, and 10 companies have completed their repurchases. FOSUN PHARMA, Allmed, and NHD had the highest repurchase amounts, totaling 600 million yuan, 100 million yuan, and 110,000 yuan respectively. Guoke Micro's repurchase amount was the highest, intending to repurchase 2.0639 million yuan"
datetime: "2025-01-22T23:55:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/225904021.md)
  - [en](https://longbridge.com/en/news/225904021.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/225904021.md)
generator: "portal-rs"
---

# 28 companies disclosed their repurchase progress, with FOSUN PHARMA, Allmed, and NHD having the highest repurchase plan amounts

On January 23, a total of 28 companies announced stock repurchase plans. Among them, 4 companies disclosed stock repurchase plans for the first time, 1 company's repurchase plan was approved by the shareholders' meeting, 13 companies disclosed the progress of stock repurchase implementation, and 10 companies have completed their repurchase plans. From the perspective of first-time disclosure of repurchase plans, 2 companies had repurchase plan amounts exceeding 10 million yuan on that day. FOSUN PHARMA, Allmed, and NHD had the highest repurchase plan amounts, intending to repurchase no more than 600 million yuan, 100 million yuan, and 110,000 yuan, respectively. In terms of repurchase plans approved by the shareholders' meeting, Guoke Micro had the highest repurchase amount, intending to repurchase no more than 2.0639 million yuan

### Related Stocks

- [600196.CN](https://longbridge.com/en/quote/600196.CN.md)
- [02196.HK](https://longbridge.com/en/quote/02196.HK.md)
- [002950.CN](https://longbridge.com/en/quote/002950.CN.md)
- [002264.CN](https://longbridge.com/en/quote/002264.CN.md)
- [300672.CN](https://longbridge.com/en/quote/300672.CN.md)
- [00656.HK](https://longbridge.com/en/quote/00656.HK.md)

## Related News & Research

- [08:27 ETClose O Matic's Step Six: How AI Sales Conversations Become Closed Sales](https://longbridge.com/en/news/297517308.md)
- [Xinhua Pharma unit Xincat’s azithromycin tablets pass China generic consistency evaluation](https://longbridge.com/en/news/297485179.md)
- [ChatGPT Health adds Epic integration for clinicians to import patient data](https://longbridge.com/en/news/297680881.md)
- [Keensight-backed DimoMaint buys Qb7, AssetPlus and Cimaint in CMMS push](https://longbridge.com/en/news/297613039.md)
- [Galle Face Capital Partners publishes annual report for year ended March 31, 2026](https://longbridge.com/en/news/297586883.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**